Finance News – U.K.
What is your interest today?
Asda is still misfiring in supermarkets’ non-existent price war | Nils Pratley
Despite significant investment aimed at boosting sales, Asda continues to lose market share, casting doubt on its ability to challenge leading competitors in the UK supermarket sec...
Read Full Article →UK watchdog fines 23andMe for 'profoundly damaging' data breach
The regulatory penalty imposed on the DNA testing company highlights financial challenges amid its bankruptcy proceedings and upcoming ownership transfer, potentially impacting its...
Read Full Article →DNA testing firm 23andMe fined £2.3m by UK regulator for 2023 data hack
The £2.3 million penalty imposed on 23andMe highlights the financial repercussions companies face for inadequate cybersecurity measures resulting in unauthorized access to sensitiv...
Read Full Article →23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
Anne Wojcicki’s increased $305 million offer to reclaim the genetic testing company surpasses previous bids, reflecting significant investor confidence despite the firm’s recent de...
Read Full Article →The smell of victory: boom in classic football shirts shows no sign of fading
The growing market for authentic vintage football jerseys has become a lucrative industry, generating substantial revenue by attracting passionate collectors willing to pay signifi...
Read Full Article →23andMe back on the auction block after former CEO makes 11th-hour bid
The recent $305 million offer from a principal insider disrupted a prior $256 million purchase deal, potentially altering the financial outcome of the company’s bankruptcy asset sa...
Read Full Article →Bankrupt DNA testing firm 23andMe to be purchased for $256m
Regeneron Pharmaceuticals’ acquisition of a consumer genetic testing company for $256 million during bankruptcy highlights a significant investment in genetic data assets, promptin...
Read Full Article →Struggling DNA testing firm 23andMe to be bought for $256m
The acquisition of 23andMe by Regeneron for $256 million highlights a notable investment in the genetic testing industry while ensuring continued commitment to safeguarding consume...
Read Full Article →